Member Info for Barnacle

Most likely ICB contracts for Feedback based on who they are working with at the moment:

NHS Greater Manchester Integrated Care Board (ICB)

Buckinghamshire, Oxfordshire & West Berkshire (BOB) Integrated Care Board (ICB)

Sussex Integrated Care Board (ICB)

Interesting listening Back to the Investors Meet Questions and Answers.

With regard to contract values:

"So we initially deployed Bleepa within an individual hospital site for a contract value in the order of £120,000.

Then we took it out into the Community Diagnostic Centers and started working between GP's diagnostic facilities and hospitals, and therefore achieved a value uplift to a contract typically of £450,000 to £600,000. But again, a slightly different decision making group that had to go with that.

Now we're taking it up to wider regional opportunities with Integrated Care Boards and some national conversations linked to the Electric Recovery Fund. But where we're looking at contract values of in the order of £2,000,000 per ICB for delivering an elective care program using this pathway approach.


So it is a very stepwise and methodical way of growing that stakeholder mapping. But we are also faced with the reality that the NHS is a very complex organisation to navigate with a lot of changes of personnel, which means that often you find you'll make progress and then key people will change out and you have to start again. So it is it is slow and it is about persistence. 


However, background work is now largely done. We have worked over the course of six years to get to the point where we are the key solution to a number of national problems, that we are at the table talking to the national leaders from the politicians, through to the Department of Health, through to NHS England, and then also across all of the regions. So we have done that groundwork. 
Now we just need to see the execution around decision making and funding, which, as we've discussed, I think is now on the verge of happening."

Looking forward to next month, and the new financial year for the NHS, we should be expecting some news shortly.

We have pilots at various CDCs and ICS, which should be concluding the end of this month:

o  Community Diagnostic Centre ("CDC") pathway pilot at the Northern Care Alliance NHS Foundation Trust ("NCA") site in Oldham.

o  Amersham CDC in Buckinghamshire

o  A pan regional pilot across Buckinghamshire, Oxfordshire and Berkshire ICS (BOB ICS)

o We also have new care pathways being implemented at Queen Victoria Hospital, Sussex.

o We have the Neighbourhood Diagnostics Pilot:

Feedback has also collaborated with a provider of primary care solutions to create a Neighbourhood Diagnostics Platform ("NDP") with a focus on increasing diagnosis and treatment in the community and the desire to shift to a digital NHS with a Digital Health Record for each patient.

The Company has since entered into a memorandum of understanding with its partner and an NHS Trust to implement a pilot, which will provide a reference point for scaling opportunities of an optimised GP referral process and subsequently the NDP. The aim is to provide a potential route to rapidly scale the Bleepa solution through a pathway approach, enabling the Government's vision of a digital-first, community centric healthcare system.

o Renewal/expansion of contract with Royal Berkshire NHS Foundation Trust.

o Renewal/expansion of contract with the Northern Care Alliance

Private:

o Pilot with Medical Imaging Partnership. Outside of the NHS, the Company successfully secured an opportunity for its technology and pathway approach within the UK private sector in partnership with MIP. This paid pilot will seek to develop a pathway approach across screening and traditional private service models and is essentially a translation of our NHS approach into the private sector.

o Go-to-market partnership with Vertex.

India :

Two revenue-generating projects operationalised in India:

o  a pilot with a large Asian hospital group

o  Tuberculosis ("TB") screening programme with HEAL Foundation

All in all, lots to look forward to.

Https://www.***markets.co.uk/articles/the-exchange-with-dr-paul-jourdan-of-amati-global-investors--fb582eb/

*replace with vox

amati global investors invested £1 million in the last fundraise, and here paul jourdan selects feedback as one of his share tips for 2025: from 62mins onwards:

https://www.**********.co.uk/articles/the-exchange-with-dr-paul-jourdan-of-amati-global-investors--fb582eb/

From 20th February 2025:

Post-fundraising Panmure readjusted its target price to 60p and rated the stock as a ‘Speculative Buy’.... Now that would be nice :0)

https://www.thearmchairtrader.com/uk-shares/feedback-staking-future-growth-on-adoption-of-bleepa-across-nhs/

Https://feedbackmedical.com/feedback-medical/queen-victoria-hospital-and-feedback-medical-win-healthcare-award/

“We are working together with QVH to expand on our success across new pathways and onboarding more sites to use Bleepa® in both primary and secondary care. We are very confident that we can replicate significant impact across other areas of the NHS.”

Dr Tom Oakley

CEO, Feedback Medical

Imagine what would happen to the share price if little old Bleepa got some of this publicity..... :0)

Https://www.linkedin.com/posts/drthomasoakley_panorama-fixing-the-nhs-what-will-it-take-activity-7310347117850472448-FOah?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAIMELYB3jCMTAJfoWG0WbiPY6veZrdjeEU

Worth a read:

https://www.linkedin.com/posts/drthomasoakley_wes-streeting-this-government-will-force-activity-7310570978294550528-61r5?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAIMELYB3jCMTAJfoWG0WbiPY6veZrdjeEU

From Linkedin 6 days ago:

"Last week our Chief Executive Officer Dr Thomas Oakley joined Mike Richards and Ian Francis to discuss the future of diagnostics and their role in the upcoming 10 year plan as part of the HSJ Events Modernising Diagnostics Forum."

Now Ian Francis was the Founder and Strategic Director at Medical Imaging Partnership, and is now Consultant Radiologist and Clinical Lead for Strategy at QVH NHS Foundation Trust.

Last February '24 Feedback entered in to a pilot agreement with MIP, news due soon.....?

Feedback opens opportunity in UK private healthcare

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the clinical infrastructure specialist, announces that radiology specialist Medical Imaging Partnership ("MIP") has agreed to pilot Bleepa-CareLocker, in order to deliver multiple clinical pathways to its customers in the UK private healthcare sector.

The agreement to pilot, enables both parties to evaluate how a pathway that enables a 'straight to diagnostic' stage followed by an 'asynchronous MDT' review, can translate from the NHS model and deliver impact within private healthcare journeys. The pilot will formally commence on a paid basis after an initial evaluation and planning period. It is anticipated that Bleepa will host a number of different diagnostic-led clinical pathways, starting initially with a novel direct access prostate screening service, pioneered by MIP, with further pathways across cardiac and Women's Health services to be onboarded later in the year.

https://www.linkedin.com/posts/feedback-medical-ltd_hsjdiagnosticsforum-activity-7308049748056236032-CzwR?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAIMELYB3jCMTAJfoWG0WbiPY6veZrdjeEU

Also topped up with another 20K this morning. Too much going on in the background to ignore.

From the news this morning:

https://www.bbc.co.uk/news/articles/c70e7lee1zko

Looking forward to the Final Results next week. Should make interesting reading. Balatro sales have remained pretty constant over the past 3 months, with at least £10M sales on Steam, plus whatever Mobile revenues might be? Abiotic Factor also still selling well, £2M in past 3 months.

Spooky ;0)

Https://feedbackmedical.com/feedback-medical/dr-tom-oakley-named-an-nhs-innovation-accelerator-fellow/

Every little bit helps :0)

All looking very positive to me, progressing nicely.

*Financing secured from Powertree; Graham White, Powertree CEO, commented: "Powertree is very pleased to form a new partnership with MED. We believe that MED has a portfolio of development assets that will become increasingly important in the net zero energy transition story. Powertree is keen to build on this first investment to build out other MED development assets."

*Successfully secured both contracts at its maximum generation capacity permissible under the CM rules; Pyebridge now has uninterrupted CM contracts until 2029 with a cumulative total guaranteed gross profit income value of c. £1.73m, over and above its PPA trading income and Embedded Benefits, Hindlip now has a cumulative total guaranteed gross profit income value of c. £6.3m (before adding CPI), subject to the site being constructed, over and above its future PPA trading income.

Increasing Revenues, and at least 15.6MW production by the end of the year.

And all valued at £800,000!

The Future of UK Energy Demand: Challenges and Opportunities in a Rapidly Expanding Market

https://www.med.energy/post/the-future-of-uk-energy-demand-challenges-and-opportunities-in-a-rapidly-expanding-market

Not sure why the drop. Financing was sorted back in October, and with a positive EBITDA, I can't see any issues on this front....

Opportunity to top up?

"The Company is also pleased to announce that it has secured a new working capital facility, ensuring support for its growth strategy through FY25. The funding takes the form of a receivables backed revolving credit facility, initially for £2m with up to £4m available over 24 months with eligible receivables over both UK and international invoices. The Board expects the facility to provide sufficient working capital for the business as it achieves its goal of an EBITDA positive run rate."

Again, so much potential, but painfully slow due to NHS bureaucracy. Enlightening to see the demo of Bleepa, and the Patient Pathway illustrated. It all makes total sense. As you've all mentioned, funding is the key to unlocking Bleepa to multiple sites which should become apparent in a month or so. Holding

Remember this? Could be huge.....

25 March 2024

New tuberculosis partnership in India

· Partnership focused on delivering CSR and donor funded screening projects

· Aim to develop a digital model that is able to scale at pace

"The focus of this partnership is to develop and drive a digital model, that is able to scale at pace, and build the case for increasing the role of technology to deliver TB screening in India, which has a population of over one billion. This will likely initially be in the form of part-funded pilot studies, which the Company anticipates would cover its core project costs, to validate the digital model ahead of commercial contracts."